Long-term potentiation (LTP) requires the activity-dependent trafficking of AMPA receptors (AMPARs) to the synapse (Collingridge et al., 2004; Malinow and Malenka, 2002; Nicoll, 2017). Most AMPARs in CA1 pyramidal cells are heterotetramers of either GluA1/GluA2 subunits or GluA2/GluA3 subunits, although other complexes can also occur (Zhao et al., 2019). The prevailing, receptor centric, LTP model, posits that LTP-mediated covalent modification of the intracellular carboxy-terminal domain (CTD, also referred to as C-tail) of GluA1 results in the capture of these modified GluA1 containing receptors by preexisting ‘slots’ in the postsynaptic density (PSD) (Hayashi et al., 2000; Huganir and Nicoll, 2013; Malinow and Malenka, 2002; Shi et al., 2001), either by increasing the surface pool of AMPARs or the docking of AMPAR at the PSD. The nature of these slots is unclear, but it is thought to involve binding sites on postsynaptic scaffolding proteins, such as PSD-95. Two phosphorylation sites in the GluA1 CTD, S831 and S845, have received most of the attention. However, the occurrence of S831 and S845 phosphorylation in vivo is a matter of debate. A recent study found the relative abundance of phosphorylated GluA1 to be ‘almost negligible’ (Hosokawa et al., 2015), but see Diering et al., 2016. The replacement by alanine of either of these residues does not affect LTP (Lee et al., 2010), and only adult double phosphomutant mice have partially impaired LTP (Lee et al., 2003). In order to determine the minimal requirement for the GluA1 CTD during LTP, a previous study Granger et al., 2013 used a conditional genetic knockout approach coupled with molecular replacement of AMPAR subunits. The Cre recombinase was transfected in CA1 pyramidal neurons in the hippocampus of Gria1, Gria2 and Gria3 floxed mice (Gria1-3^fl/fl), in order to delete all endogenous AMPARs in Lu et al., 2009. We then expressed various modified GluA subunits upon this AMPAR null background. In the most relevant experiment in our study, we expressed a heteromeric receptor containing the GluA1 subunit lacking the CTD (GluA1ΔC) as well as GluA2, and observed normal basal trafficking and LTP at CA1 synapses in acute hippocampal slices. We therefore concluded that AMPAR lacking the GluA1 subunit CTD can traffic normally to the synapse and enable normal LTP (Granger et al., 2013). These findings appear to be incompatible with the receptor centric model and the requirement of the GluA1 CTD for LTP.

A recent study has resurrected the receptor centric model of LTP (Zhou et al., 2018). The authors generated a knock-in (KI) mouse, in which they replaced the endogenous GluA1 with a chimeric GluA1 subunit that contains the CTD of GluA2 (GluA1A2CTD). They found that, while basal synaptic transmission was normal in this mouse, LTP was absent. Furthermore, a complementary chimeric AMPAR subunit, GluA2A1CTD, fully rescued LTP. Thus, the authors concluded that the CTD of GluA1 is ‘necessary and sufficient’ for NMDAR dependent LTP. What could explain this seeming contradiction? The present study addresses the discrepancy between the previous works (Granger et al., 2013; Zhou et al., 2018).

To address this discrepancy, we aimed to replicate the key experiments in Zhou et al. using overexpression and molecular replacement strategies (Díaz-Alonso et al., 2017; Granger et al., 2013). We previously showed that replacement of endogenous GluA2 subunits with GluA1/A2CTD resulted in functional AMPARs, which supported homeostatic synaptic scaling (Ancona Esselmann et al., 2017). Furthermore, overexpression of this construct in hippocampal slice cultures generated rectifying synaptic responses (Figure 1—figure supplement 1A,B), confirming that this construct forms functional homomeric receptors which traffic to the synapse constitutively. We next replaced all endogenous AMPARs with heteromeric GluA1/A2CTD-GluA2 receptors in hippocampal CA1 pyramidal neurons. To do so, we electroporated Cre recombinase in utero in Gria1-3^f/f mice (where all AMPAR subunits expressed in CA1 pyramidal neurons are floxed) together with GluA1/A2CTD and GluA2(R) (Figure 1A). Acute slices were prepared at P17-P25. Synaptic AMPARs were fully rescued (Figure 1B). Unlike replacement with GluA1/A2CTD alone, which results in strongly rectifying, homomeric AMPARs (Figure 1—figure supplement 2B), synaptic currents were non-rectifying in GluA1/A2CTD-GluA2(R) expressing neurons (Figure 1—figure supplement 2A,C), confirming that the expressed subunits form heteromeric receptors. These receptors exhibit normal LTP (Figure 1C). Trying to replicate the experiments reported by Zhou et al. more closely, we selectively replaced endogenous GluA1, which we deleted using CRISPR/Cas9 technology, with GluA1/A2CTD (Figure 1D). We initially tested the efficacy of the CRISPR/Cas9 guided GluA1 knockdown strategy in a heterologous system, 293 T cells. Co-transfection of a Gria1 gRNA/Cas9 expressing vector in cells expressing GluA1 virtually eliminated the GluA1 protein (Figure 1—figure supplement 3A). We then tested the efficacy of the Gria1 gRNA/Cas9 construct in hippocampal slices. Similar to the results obtained using the conditional KO of GluA1 using Cre-loxP (Granger et al., 2013; Lu et al., 2009), we observed a ~50% loss of AMPAR EPSCs when expressing the Gria1 gRNA/Cas9 in rat slice cultures and mouse acute slices (therefore, data were pooled, Figure 1—figure supplement 3B,C). NMDAR EPSCs remained unchanged (Figure 1—figure supplement 3D). LTP was absent (Figure 1—figure supplement 3E), in agreement with previous results, likely due to the lack of a sufficient reserve pool of receptors (Granger et al., 2013; Zamanillo et al., 1999). The endogenous GluA1 was then replaced with GluA1/A2CTD*, where the sequence recognized by the Gria1 gRNA was replaced by another which translates to the same protein sequence (Figure 1D, Figure 1—figure supplement 3A, Materials and methods). GluA1/A2CTD* expression rescued basal synaptic transmission (Figure 1E) and LTP (Figure 1F). NMDAR EPSCs were normal in transfected cells (Figure 1—figure supplement 3F).

Figure 1 with 3 supplements see all

Download asset Open asset

Figure 1—source data 1

Contains source data for Figure 1.

GluA1/A2CTD supports LTP.

https://cdn.elifesciences.org/articles/58042/elife-58042-fig1-data1-v2.xlsx

Download elife-58042-fig1-data1-v2.xlsx

The only remaining difference in the experimental approach between our study and that of Zhou et al. is that they used the endogenous promoter to express GluA1/A2CTD, while we used overexpression. Thus, to unequivocally assess the necessity of the GluA1 CTD for LTP, we generated a KI mouse where the endogenous GluA1 CTD is truncated (HA-ΔCTD GluA1, Figure 2A, Figure 2—figure supplement 1, Materials and methods). Any LTP present in this mouse must, therefore, be independent of the GluA1 CTD. A number of experiments confirmed that our KI mouse did, indeed, lack the GluA1 CTD. Western blots were performed using antibodies to the ATD of GluA1, the CTD of GluA1 and the HA tag in synaptosomal-enriched P2 fractions (Figure 2B). The HA tag, which we attached to the truncated C-terminus to identify the ΔCTD GluA1 subunit, is present in both the heterozygous and the homozygous KI mice, but, as expected, is absent from WT mice. The CTD directed antibody labeled the WT and heterozygous, but not the homozygous KI mouse. The ATD-directed antibody demonstrated the presence of GluA1 at normal levels in the KI mouse, where, as expected, the protein size is reduced due to the lack of the C-terminal 77 amino acids. Immunoblot against the GluA2 CTD and NR1 showed normal levels of these synaptic proteins in the KI (Figure 2B). Truncation of the GluA1 CTD was further confirmed with immunofluorescence using a GluA1 CTD antibody, which yielded strong staining in the WT hippocampal CA1 region, but no staining in the KI mouse (Figure 2C). AMPAR responses recorded from somatic outside out patches were unchanged in the KI mouse (Figure 2D). This is particularly important, because LTP expression is critically dependent on the level of extrasynaptic AMPARs (Granger et al., 2013). Furthermore, there was no change in the AMPAR/NMDAR ratio, consistent with a normal number of synaptic AMPARs (Figure 2E). Pairing-induced LTP (2 Hz/90 s. stimuli, while holding the postsynaptic neuron at 0 mV) in these KI mice was no different from WT controls (Figure 2F). To obtain an independent analysis of these mice, we collaborated with another group (R.C. Malenka and W. Morishita, Stanford University) who induced LTP with a different pairing protocol consisting of two stimulus bouts of 100 Hz/1 s. while holding the postsynaptic neuron at 0 mV. Again, no impairment in LTP was observed (Figure 2G).

Figure 2 with 1 supplement see all

Download asset Open asset

Figure 2—source data 1

Contains source data for Figure 2.

GluA1 CTD is not required for AMPAR trafficking and LTP.

https://cdn.elifesciences.org/articles/58042/elife-58042-fig2-data1-v2.xlsx

Download elife-58042-fig2-data1-v2.xlsx

In a final series of experiments, we tested hippocampal spatial learning and memory in these mice using the Morris water maze, a behavioral test that was shown to be impaired in GluA1A2CTD mice (Zhou et al., 2018). No statistically significant difference between WT and HA-ΔCTD GluA1 mice was found in either the distance travelled to find the hidden platform during training (Figure 3A), or in the ability to remember the position of the platform 24 hr after the last training session (Figure 3B, Figure 3—figure supplement 1C). HA-ΔCTD GluA1 mice showed a reduced swim speed across the training and test sessions (Figure 3—figure supplement 1A,E), which increased their latency to find the platform during training (Figure 3—figure supplement 1B), and resulted in a not significant trend toward increased latency to the first platform crossing in the probe trial (Figure 3—figure supplement 1D).

Figure 3 with 1 supplement see all

Download asset Open asset

Figure 3—source data 1

Contains source data for Figure 3.

GluA1 CTD is not essential for spatial learning and memory.

https://cdn.elifesciences.org/articles/58042/elife-58042-fig3-data1-v2.xlsx

Download elife-58042-fig3-data1-v2.xlsx

This study addressed whether the CTD of GluA1 is required for LTP and spatial memory, as recently reported (Zhou et al., 2018). We were unable to replicate these previous LTP results when we replaced endogenous GluA1 with GluA1/A2CTD using in utero electroporation. To test whether the high expression levels of the GluA1/A2CTD construct achieved by overexpression were masking LTP deficits, we generated a more conclusive KI mouse model. Instead of knocking in GluA1/A2CTD, as was done in the previous study, we truncated the CTD of the endogenous GluA1 (HA-ΔCTD GluA1) after the EFCY sequence following the last transmembrane helix of the polypeptide. Of note, this sequence is homologous in GluA1 and GluA2, so there is virtually no GluA1-specific CTD in this mouse. No defect in basal synaptic transmission, LTP, or spatial memory was found. What could account for the different results? By design, our LTP induction protocol is nearly-saturating, so that we can identify key, essential components of LTP. It is possible that a weaker induction protocol could reveal some subtle defects caused by the lack of the GluA1 CTD. However, Zhou et al. used a protocol similar to ours (cesium based internal solution with 100 Hz/1 s. tetanus repeated four times, see their Figure 7b). This LTP induction protocol would be at least as strong as ours, but they found no LTP in their GluA1A2CTD KI mouse.

Given that GluA1 KO mice show no spatial learning defects in the Morris water maze (Zamanillo et al., 1999), it is not surprising that mice lacking the GluA1 CTD did not show a spatial learning impairment in our study either. The severe deficits found in spatial learning and memory in GluA1/A2CTD KI mice are, therefore, puzzling. Of note, both GluA1 KO (Zamanillo et al., 1999) and HA-ΔCTD GluA1 (Figure 3—figure supplement 1A,E) mice show decreased swim speed compared to their WT controls, a possible confounding factor suggesting that the GluA1 CTD might be involved in this locomotor function. Future research will allow the dissection of the precise role played by the GluA1 CTD in locomotion and spatial memory, as well as other physiological and behavioral functions.

A large body of research has suggested that the GluA1 CTD modulates AMPAR trafficking and synaptic plasticity. We refer to these findings as the ‘receptor centric’ model of LTP, in which the LTP signaling pathway, presumed to involve CaMKII, targets the receptor, increasing the capture of modified receptors by preexisting slots in the PSD. Although we failed to find a fundamental requirement for the GluA1 CTD in AMPAR synaptic transmission, LTP and spatial memory, it has previously been shown that posttranslational modifications targeting this domain are involved in the modulation of these phenomena, particularly LTP. Multiple reasons might explain the apparent conflict between our results and previous research. Perhaps, the well-established phosphorylation of GluA1 C-tail residues (particularly S831 and S845) (Barria et al., 1997; Esteban et al., 2003; Hayashi et al., 2000; Lee et al., 2003; Mammen et al., 1997; Roche et al., 1996) is crucial to relieve some, yet unidentified, negative modulatory effect exerted by other part(s) of the GluA1 C-tail, this negative modulation being absent in HA-ΔCTD GluA1 mice and in cells expressing GluA1/A2CTD. Our study was designed to assess the necessity of the GluA1 CTD in hippocampal LTP. Our data indicate that LTP does not require the GluA1 CTD and is, therefore, consistent with a model where LTP can occur independently of the subunit composition of AMPAR, in agreement with a previous study (Granger et al., 2013). More broadly, our results suggest an alternative model, which we refer to as the ‘PSD centric model’ for LTP, in which the LTP signal creates/unmasks new slots in the PSD that capture passively diffusing, unmodified AMPARs.

Based on recent findings from us and others (Díaz-Alonso et al., 2017; Sheng et al., 2018; Watson et al., 2017; Watson et al., 2020; Zeng et al., 2019), we propose that constitutive and activity-dependent AMPAR trafficking has two essential requirements. On one hand, the multivalent interaction between transmembrane AMPAR regulatory proteins (TARPs) and PSD scaffolding proteins (the intracellular slot). On the other hand, the presence of the GluA1 amino-terminal domain and its interaction with yet to be identified extracellular synaptic cleft moieties (the extracellular slot). This emerging model predicts that the activity-regulated availability of both intracellular and extracellular slots can modulate the abundance of functional AMPARs at the synapse.

All data generated or analysed during this study are included in the manuscript and supporting files.

1. 1. Ancona Esselmann SG
   2. Díaz-Alonso J
   3. Levy JM
   4. Bemben MA
   5. Nicoll RA

   (2017) Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2

   PNAS 114:13266–13271.

   https://doi.org/10.1073/pnas.1716022114

   • PubMed
   • Google Scholar
2. 1. Barria A
   2. Muller D
   3. Derkach V
   4. Griffith LC
   5. Soderling TR

   (1997) Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation

   Science 276:2042–2045.

   https://doi.org/10.1126/science.276.5321.2042

   • PubMed
   • Google Scholar
3. 1. Bemben MA
   2. Shipman SL
   3. Hirai T
   4. Herring BE
   5. Li Y
   6. Badger JD
   7. Nicoll RA
   8. Diamond JS
   9. Roche KW

   (2014) CaMKII phosphorylation of neuroligin-1 regulates excitatory synapses

   Nature Neuroscience 17:56–64.

   https://doi.org/10.1038/nn.3601

   • PubMed
   • Google Scholar
4. 1. Collingridge GL
   2. Isaac JT
   3. Wang YT

   (2004) Receptor trafficking and synaptic plasticity

   Nature Reviews Neuroscience 5:952–962.

   https://doi.org/10.1038/nrn1556

   • PubMed
   • Google Scholar
5. 1. Díaz-Alonso J
   2. Sun YJ
   3. Granger AJ
   4. Levy JM
   5. Blankenship SM
   6. Nicoll RA

   (2017) Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting

   PNAS 114:7136–7141.

   https://doi.org/10.1073/pnas.1707472114

   • PubMed
   • Google Scholar
6. 1. Diering GH
   2. Heo S
   3. Hussain NK
   4. Liu B
   5. Huganir RL

   (2016) Extensive phosphorylation of AMPA receptors in neurons

   PNAS 113:E4920–E4927.

   https://doi.org/10.1073/pnas.1610631113

   • PubMed
   • Google Scholar
7. 1. Esteban JA
   2. Shi SH
   3. Wilson C
   4. Nuriya M
   5. Huganir RL
   6. Malinow R

   (2003) PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity

   Nature Neuroscience 6:136–143.

   https://doi.org/10.1038/nn997

   • PubMed
   • Google Scholar
8. 1. Granger AJ
   2. Shi Y
   3. Lu W
   4. Cerpas M
   5. Nicoll RA

   (2013) LTP requires a reserve pool of glutamate receptors independent of subunit type

   Nature 493:495–500.

   https://doi.org/10.1038/nature11775

   • PubMed
   • Google Scholar
9. 1. Hayashi Y
   2. Shi SH
   3. Esteban JA
   4. Piccini A
   5. Poncer JC
   6. Malinow R

   (2000) Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction

   Science 287:2262–2267.

   https://doi.org/10.1126/science.287.5461.2262

   • PubMed
   • Google Scholar
10. 1. Hosokawa T
    2. Mitsushima D
    3. Kaneko R
    4. Hayashi Y

    (2015) Stoichiometry and phosphoisotypes of hippocampal AMPA-type glutamate receptor phosphorylation

    Neuron 85:60–67.

    https://doi.org/10.1016/j.neuron.2014.11.026

    • PubMed
    • Google Scholar
11. 1. Huganir RL
    2. Nicoll RA

    (2013) AMPARs and synaptic plasticity: the last 25 years

    Neuron 80:704–717.

    https://doi.org/10.1016/j.neuron.2013.10.025

    • PubMed
    • Google Scholar
12. 1. Incontro S
    2. Asensio CS
    3. Edwards RH
    4. Nicoll RA

    (2014) Efficient, complete deletion of synaptic proteins using CRISPR

    Neuron 83:1051–1057.

    https://doi.org/10.1016/j.neuron.2014.07.043

    • PubMed
    • Google Scholar
13. 1. Lee HK
    2. Takamiya K
    3. Han JS
    4. Man H
    5. Kim CH
    6. Rumbaugh G
    7. Yu S
    8. Ding L
    9. He C
    10. Petralia RS
    11. Wenthold RJ
    12. Gallagher M
    13. Huganir RL

    (2003) Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory

    Cell 112:631–643.

    https://doi.org/10.1016/S0092-8674(03)00122-3

    • PubMed
    • Google Scholar
14. 1. Lee HK
    2. Takamiya K
    3. He K
    4. Song L
    5. Huganir RL

    (2010) Specific roles of AMPA receptor subunit GluR1 (GluA1) phosphorylation sites in regulating synaptic plasticity in the CA1 region of Hippocampus

    Journal of Neurophysiology 103:479–489.

    https://doi.org/10.1152/jn.00835.2009

    • PubMed
    • Google Scholar
15. 1. Lu W
    2. Shi Y
    3. Jackson AC
    4. Bjorgan K
    5. During MJ
    6. Sprengel R
    7. Seeburg PH
    8. Nicoll RA

    (2009) Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach

    Neuron 62:254–268.

    https://doi.org/10.1016/j.neuron.2009.02.027

    • PubMed
    • Google Scholar
16. 1. Malinow R
    2. Malenka RC

    (2002) AMPA receptor trafficking and synaptic plasticity

    Annual Review of Neuroscience 25:103–126.

    https://doi.org/10.1146/annurev.neuro.25.112701.142758

    • PubMed
    • Google Scholar
17. 1. Mammen AL
    2. Kameyama K
    3. Roche KW
    4. Huganir RL

    (1997) Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II

    Journal of Biological Chemistry 272:32528–32533.

    https://doi.org/10.1074/jbc.272.51.32528

    • PubMed
    • Google Scholar
18. 1. Navarro-Quiroga I
    2. Chittajallu R
    3. Gallo V
    4. Haydar TF

    (2007) Long-term, selective gene expression in developing and adult hippocampal pyramidal neurons using focal in utero electroporation

    Journal of Neuroscience 27:5007–5011.

    https://doi.org/10.1523/JNEUROSCI.0867-07.2007

    • PubMed
    • Google Scholar
19. 1. Nicoll RA

    (2017) A brief history of Long-Term potentiation

    Neuron 93:281–290.

    https://doi.org/10.1016/j.neuron.2016.12.015

    • PubMed
    • Google Scholar
20. 1. Orr AG
    2. Lo I
    3. Schumacher H
    4. Ho K
    5. Gill M
    6. Guo W
    7. Kim DH
    8. Knox A
    9. Saito T
    10. Saido TC
    11. Simms J
    12. Toddes C
    13. Wang X
    14. Yu GQ
    15. Mucke L

    (2018) Istradefylline reduces memory deficits in aging mice with amyloid pathology

    Neurobiology of Disease 110:29–36.

    https://doi.org/10.1016/j.nbd.2017.10.014

    • PubMed
    • Google Scholar
21. 1. Platt RJ
    2. Chen S
    3. Zhou Y
    4. Yim MJ
    5. Swiech L
    6. Kempton HR
    7. Dahlman JE
    8. Parnas O
    9. Eisenhaure TM
    10. Jovanovic M
    11. Graham DB
    12. Jhunjhunwala S
    13. Heidenreich M
    14. Xavier RJ
    15. Langer R
    16. Anderson DG
    17. Hacohen N
    18. Regev A
    19. Feng G
    20. Sharp PA
    21. Zhang F

    (2014) CRISPR-Cas9 knockin mice for genome editing and Cancer modeling

    Cell 159:440–455.

    https://doi.org/10.1016/j.cell.2014.09.014

    • PubMed
    • Google Scholar
22. 1. Ran FA
    2. Hsu PD
    3. Wright J
    4. Agarwala V
    5. Scott DA
    6. Zhang F

    (2013) Genome engineering using the CRISPR-Cas9 system

    Nature Protocols 8:2281–2308.

    https://doi.org/10.1038/nprot.2013.143

    • Google Scholar
23. 1. Roche KW
    2. O'Brien RJ
    3. Mammen AL
    4. Bernhardt J
    5. Huganir RL

    (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit

    Neuron 16:1179–1188.

    https://doi.org/10.1016/S0896-6273(00)80144-0

    • PubMed
    • Google Scholar
24. 1. Schnell E
    2. Sizemore M
    3. Karimzadegan S
    4. Chen L
    5. Bredt DS
    6. Nicoll RA

    (2002) Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number

    PNAS 99:13902–13907.

    https://doi.org/10.1073/pnas.172511199

    • PubMed
    • Google Scholar
25. 1. Sheng N
    2. Bemben MA
    3. Díaz-Alonso J
    4. Tao W
    5. Shi YS
    6. Nicoll RA

    (2018) LTP requires postsynaptic PDZ-domain interactions with glutamate receptor/auxiliary protein complexes

    PNAS 115:3948–3953.

    https://doi.org/10.1073/pnas.1800719115

    • PubMed
    • Google Scholar
26. 1. Shi S
    2. Hayashi Y
    3. Esteban JA
    4. Malinow R

    (2001) Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons

    Cell 105:331–343.

    https://doi.org/10.1016/S0092-8674(01)00321-X

    • PubMed
    • Google Scholar
27. 1. Stoppini L
    2. Buchs PA
    3. Muller D

    (1991) A simple method for organotypic cultures of nervous tissue

    Journal of Neuroscience Methods 37:173–182.

    https://doi.org/10.1016/0165-0270(91)90128-M

    • PubMed
    • Google Scholar
28. 1. Watson JF
    2. Ho H
    3. Greger IH

    (2017) Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain

    eLife 6:e23024.

    https://doi.org/10.7554/eLife.23024

    • PubMed
    • Google Scholar
29. Preprint

    1. Watson JF
    2. Pinggera A
    3. Ho H

    (2020) AMPA receptor anchoring at CA1 synapses is determined by an interplay of N- terminal domain and TARP γ8 interactions

    bioRxiv.

    https://doi.org/10.1101/2020.07.09.196154

    • Google Scholar
30. 1. Zamanillo D
    2. Sprengel R
    3. Hvalby O
    4. Jensen V
    5. Burnashev N
    6. Rozov A
    7. Kaiser KM
    8. Köster HJ
    9. Borchardt T
    10. Worley P
    11. Lübke J
    12. Frotscher M
    13. Kelly PH
    14. Sommer B
    15. Andersen P
    16. Seeburg PH
    17. Sakmann B

    (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning

    Science 284:1805–1811.

    https://doi.org/10.1126/science.284.5421.1805

    • PubMed
    • Google Scholar
31. 1. Zeng M
    2. Díaz-Alonso J
    3. Ye F
    4. Chen X
    5. Xu J
    6. Ji Z
    7. Nicoll RA
    8. Zhang M

    (2019) Phase Separation-Mediated TARP/MAGUK complex condensation and AMPA receptor synaptic transmission

    Neuron 104:529–543.

    https://doi.org/10.1016/j.neuron.2019.08.001

    • Google Scholar
32. 1. Zhao Y
    2. Chen S
    3. Swensen AC
    4. Qian WJ
    5. Gouaux E

    (2019) Architecture and subunit arrangement of native AMPA receptors elucidated by cryo-EM

    Science 364:355–362.

    https://doi.org/10.1126/science.aaw8250

    • PubMed
    • Google Scholar
33. 1. Zhou Z
    2. Liu A
    3. Xia S
    4. Leung C
    5. Qi J
    6. Meng Y
    7. Xie W
    8. Park P
    9. Collingridge GL
    10. Jia Z

    (2018) The C-terminal tails of endogenous GluA1 and GluA2 differentially contribute to hippocampal synaptic plasticity and learning

    Nature Neuroscience 21:50–62.

    https://doi.org/10.1038/s41593-017-0030-z

    • PubMed
    • Google Scholar

Author details

1. Javier Díaz-Alonso

   Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States

   Present address

   Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, United States

   Contribution

   Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Writing - original draft, Project administration

   For correspondence

   jdiazalo@uci.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-4980-7441

2. Wade Morishita

   Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, United States

   Contribution

   Data curation, Formal analysis, Validation, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

3. Salvatore Incontro

   Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States

   Contribution

   Validation, Investigation

   Competing interests

   No competing interests declared

4. Jeffrey Simms

   Gladstone Institute of Neurological Disease, San Francisco, United States

   Contribution

   Data curation, Formal analysis, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

5. Julia Holtzman

   Gladstone Institute of Neurological Disease, San Francisco, United States

   Contribution

   Formal analysis, Investigation

   Competing interests

   No competing interests declared

6. Michael Gill

   Gladstone Institute of Neurological Disease, San Francisco, United States

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

7. Lennart Mucke

   1. Gladstone Institute of Neurological Disease, San Francisco, United States
   2. Department of Neurology, University of California, San Francisco, San Francisco, United States

   Contribution

   Data curation, Formal analysis, Supervision, Writing - review and editing

   Competing interests

   No competing interests declared

8. Robert C Malenka

   Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, United States

   Contribution

   Funding acquisition, Project administration, Writing - review and editing

   Competing interests

   No competing interests declared

9. Roger A Nicoll

   Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States

   Contribution

   Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing - original draft, Project administration

   For correspondence

   roger.nicoll@ucsf.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-6977-4632

• 2,680

  views

• 491

  downloads

• 30

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.